Activatable zymography probes enable in situ localization of protease dysregulation in cancer
©2020 American Association for Cancer Research. Recent years have seen the emergence of conditionally activated diagnostics and therapeutics that leverage protease-cleavable peptide linkers to enhance their specificity for cancer. However, due to a lack of methods to measure and localize protease ac...
Main Authors: | Soleimany, Ava P, Kirkpatrick, Jesse D, Su, Susan, Dudani, Jaideep S, Zhong, Qian, Bekdemir, Ahmet, Bhatia, Sangeeta N |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association for Cancer Research (AACR)
2021
|
Online Access: | https://hdl.handle.net/1721.1/134556 |
Similar Items
-
Activatable zymography probes enable in situ localization of protease dysregulation in cancer
by: Soleimany, Ava P., et al.
Published: (2022) -
Novel Ex Vivo Zymography Approach for Assessment of Protease Activity in Tissues with Activatable Antibodies
by: Bruce Howng, et al.
Published: (2021-09-01) -
Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosis
by: Kirkpatrick, Jesse D, et al.
Published: (2022) -
Classification of prostate cancer using a protease activity nanosensor library
by: Dudani, Jaideep S, et al.
Published: (2022) -
Classification of prostate cancer using a protease activity nanosensor library
by: Dudani, Jaideep S, et al.
Published: (2021)